There are 1,269 papers on metabolic disease in aging research: 40 trials and 269 observational studies in people, 133 in animals, 1 in cells, 791 reviews.
159 new papers in 30 daysSee all 2,687 papers on metabolic disease
At a glance
Metabolic disease is linked with higher vascular dementia risk and worse cognitive function in human studies. Obesity, including in older adults, and vitamin B12 or D deficiency in patients with obesity are associated with metabolic disease. In mice, time-restricted feeding protects circadian clock knockout animals, while nicotinamide riboside protects against high-fat diet-induced metabolic disease.
151 findings in 138 papers from 2012 to 2026, 23 of them since April 2026
“Animal-food diet is associated with a range of metabolic diseases”
- Human trial40
- Humans269
- Animals129
- Model organisms4
- Cells1
- In silico24
Interventions
30Exercise
downin reviews2downin humans1
3 studies
Exercise
downin reviews2downin humans1
Exercise decreases metabolic disease (physical activity combined with calorie restriction).
“Physical activity combined with calorie restriction can effectively reduce metabolic disease and chronic inflammation, alleviating the adverse effects of weight cycling on the body.”
Reviewphysical activity combined with calorie restriction
The Impact of Weight Cycling on Health and Obesity
Metabolites
Exercise decreases metabolic disease in advancing ageing and age-related diseases.
“exercise alleviates metabolic diseases in individuals with advancing ageing and age-related diseases by the remarkable promotion of mitochondrial biogenesis and function”
Reviewin advancing ageing and age-related diseases
Exercise mitigates age-related metabolic diseases by improving mitochondrial dysfunction
Ageing research reviews
Exercise protects against metabolic disease in humans.
“Exercise drives metabolic integration between muscle, adipose and liver metabolism and protects against aging-related diseases”
Review
Experimental gerontology
Lifestyle modification
downin humans2
2 studies
Lifestyle modification
downin humans2
Lifestyle modification protects against metabolic disease in patients with mental disorders treated with antipsychotics.
“The basis of prevention is lifestyle modification through small, gradual steps easier to maintain over the long term.”
Reviewin patients with mental disorders treated with antipsychotics
Psychiatria polska
Lifestyle modification prevents metabolic disease in humans.
“Public health interventions targeting modifiable risk factors can effectively promote healthier lifestyles and prevent metabolic diseases.”
Review
Frontiers in public health
Berberine
downin reviews2
2 studies
Berberine
downin reviews2
Berberine decreases metabolic disease.
“Studies have shown that BBR can alleviate the pathological conditions of metabolic disorders, and the mechanism is related to the regulation of gut microbiota”
Review
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Frontiers in cellular and infection microbiology
Berberine protects against metabolic disease.
“Lycopene and berberine are natural plants with a wide range of beneficial effects including protective activities against metabolic disorders such as diabetes and cardiovascular diseases.”
Review
Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review
European journal of pharmacology
Caloric restriction
downin reviews2
2 studies
Caloric restriction
downin reviews2
Caloric restriction prevents metabolic disease.
“In addition to preventing metabolic disorders”
Review
Frontiers in physiology
Caloric restriction prevents metabolic disease.
“Caloric restriction helps to prevent such metabolic disorders”
Review
Biochemistry. Biokhimiia
Metformin
downin humans1
1 study
Metformin
downin humans1
Metformin prevents metabolic disease in humans.
“consideration should be given to the introduction of metformin treatment at a dose of 1,000-2,000 mg/day, as the best-documented, safe, and inexpensive pharmacological method for preventing the development of metabolic disorders”
Reviewin patients receiving antipsychotics with weight gain, diagnostic abnormalities, metabolic risk factors, or high metabolic risk APs1,000-2,000 mg/day
Psychiatria polska
Taurine
downin reviews1
1 study
Taurine
downin reviews1
Taurine protects against metabolic disease.
“the protective effects and molecular mechanisms of taurine in metabolism‐related diseases such as diabetes”
Review
Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications
Food Frontiers
Organoid therapy
downin reviews1
1 study
Organoid therapy
downin reviews1
Organoid therapy decreases metabolic disease.
“engineered organoids have been successfully applied to restore hair-bearing skin, repair colonic epithelial continuity, bridge critical-size bone defects, and correct metabolic disorders.”
Reviewengineered
Engineering organoids toward implantable living therapeutics
hLife
Circadian rhythm disruption combined with a high-fat, high-sugar diet
upin mice1
1 study
Circadian rhythm disruption combined with a high-fat, high-sugar diet
upin mice1
Circadian rhythm disruption combined with a high-fat, high-sugar diet increases metabolic disease in mice.
“Compared with controls, the composite model showed more severe metabolic disorders, including increased body weight, elevated fasting glucose and lipid levels, and marked hepatic steatosis”
ReviewC57BL/6J composite model compared with single-factor high-fat, high-sugar diet and circadian disruption controls
Journal of visualized experiments : JoVE
More on Circadian rhythm disruption combined with a high-fat, high-sugar diet
Stem cell therapy
downin reviews1
1 study
Stem cell therapy
downin reviews1
Stem cell therapy decreases metabolic disease.
“the application of SCs along with antioxidants, to mitigate oxidative stress-induced metabolic disorders.”
Review
ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy
Pathology, research and practice
FOXO-targeting compounds
downin reviews1
1 study
FOXO-targeting compounds
downin reviews1
FOXO-targeting compounds decrease metabolic disease.
“These FOXO-targeting compounds demonstrate great potential in improving metabolic disorders and delaying the onset of aging phenotypes.”
Review
FOXO: a key target in regulating aging and age-related diseases
Biogerontology
All 30Fewer
Effects
9Muscle echointensity
upin humans1
1 study
Muscle echointensity
upin humans1
Metabolic disease is linked with higher muscle echointensity in humans (compared to the control group) (p < 0.05).
“The tibialis anterior muscle had higher echointensity values in the metabolic disease group ( p < 0.05).”
Humanscompared to the control grouptibialis anterior musclen = 68
Сибирский журнал клинической и экспериментальной медицины
Muscle mass
downin humans1
1 study
Muscle mass
downin humans1
Metabolic disease is linked with lower muscle mass in humans (compared to the control group).
“the rectus femoris was characterized by decreased pennation angle, anatomical cross-sectional area (CSA), physiological CSA, and muscle volume”
Humanscompared to the control grouprectus femorisn = 68
Сибирский журнал клинической и экспериментальной медицины
Trabecular bone score
downin humans1
1 study
Trabecular bone score
downin humans1
Metabolic disease is linked with lower trabecular bone score in patients with Turner syndrome.
“The presence of metabolic diseases appeared to have a negative influence on TBS (p=0.034).”
Humansin patients with Turner syndromefemales
Impact of Clinical Factors on Bone Microarchitecture in Patients with Turner Syndrome
Endocrine, metabolic & immune disorders drug targets
Physiological decline
upin reviews1
1 study
Physiological decline
upin reviews1
Metabolic disease induces physiological decline.
“Aging and metabolic diseases are intricately linked through bidirectional molecular mechanisms that foster a harmful cycle of physiological decline.”
Review
Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons
Medical review (2021)
Extracellular vesicle secretion
downin reviews1
1 study
Extracellular vesicle secretion
downin reviews1
Metabolic disease impairs extracellular vesicle secretion.
“aging and metabolic diseases impair EV biogenesis and secretion”
Review
Preprints.orgPreprint
Cognitive function
downin humans1
1 study
Cognitive function
downin humans1
Metabolic disease is linked with worse cognitive function in humans (particularly diabetes and hypertension).
“Metabolic disorders-particularly diabetes and hypertension-were associated with worse cognitive performance”
Humansparticularly diabetes and hypertension
The interplay between metabolic health factors and stroke incidence in aging populations
Frontiers in endocrinology
Ovarian aging
upin reviews1
1 study
Ovarian aging
upin reviews1
Metabolic disease increases ovarian aging.
“It has been reported that metabolic disorder may significantly contribute to ovarian aging.”
Review
Metabolic disorder: the dark side of ovarian aging
Trends in molecular medicine
Bioactivity of adult-derived mesenchymal stem cells
downin reviews1
1 study
Bioactivity of adult-derived mesenchymal stem cells
downin reviews1
Metabolic disease impairs bioactivity of adult-derived mesenchymal stem cells.
“aging and metabolic diseases negatively impact the bioactivity of adult-derived MSCs”
Review
Frontiers in cell and developmental biology
Cellular senescence
upin reviews1
1 study
Cellular senescence
upin reviews1
Metabolic disease induces cellular senescence.
“metabolic diseases, which in turn promote senescence.”
Review
The metabolic roots of senescence: mechanisms and opportunities for intervention
Nature metabolism
Upstream
10Metabolic flexibility
downin reviews1
1 study
Metabolic flexibility
downin reviews1
metabolic flexibility protects against metabolic disease.
“Its remarkable capacity for dynamic adaptation, termed metabolic flexibility, underpins physical performance and protects against metabolic diseases such as obesity, type 2 diabetes, and sarcopenia.”
Reviewskeletal muscle
iScience
YY1
upin mice1
1 study
YY1
upin mice1
YY1 increases metabolic disease in mice (on high-fat diet; shown by adipocyte-specific knockout).
“YAKO mice showed alleviation of HFD-induced metabolic disorders”
Animalson high-fat diet; shown by adipocyte-specific knockout
Diabetes
TERT
downin mice1
1 study
TERT
downin mice1
TERT decreases metabolic disease in obesity.
“Conditional expression of mTERT reduces metabolic disorders associated with obesity.”
Animalsin obesity
bioRxiv (Cold Spring Harbor Laboratory)Preprint
TFEB
downin mice1
1 study
TFEB
downin mice1
TFEB prevents metabolic disease in mice (shown by proximal tubule-specific Tfeb knockout).
“TFEB deficiency in the proximal tubules caused metabolic disorders and occasionally led to apolipoprotein A4 (APOA4) amyloidosis”
Animalsshown by proximal tubule-specific Tfeb knockoutproximal tubules
JCI insight
cd24-siglec-e axis
downin mice1
1 study
cd24-siglec-e axis
downin mice1
cd24-siglec-e axis protects against metabolic disease in mice (diet-induced metabolic disorders).
“Inactivation of the CD24-Siglec-E pathway exacerbates, while CD24Fc treatment alleviates, diet-induced metabolic disorders, including obesity, dyslipidemia, insulin resistance, and nonalcoholic steatohepatitis (NASH).”
Animalsdiet-induced metabolic disorders
CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder
Cell metabolism
Sphingosine-1-phosphate
mediatesin reviews1
1 study
Sphingosine-1-phosphate
mediatesin reviews1
Sphingosine-1-phosphate mediates metabolic disease.
“changes in the S1P axis (i.e., S1P production, transport, and receptors) may modify metabolism and eventually mediate metabolic diseases.”
Review
Sphingosine-1-phosphate in mitochondrial function and metabolic diseases
Obesity reviews : an official journal of the International Association for the Study of Obesity
Inflammation
upin reviews1
1 study
Inflammation
upin reviews1
Inflammation induces metabolic disease under metabolic stress.
“This activation of different cell types in the hypothalamus leads to chronic, low-grade inflammation, impairing energy balance and contributing to defective feeding habits, thermogenesis, and insulin and leptin signaling, eventually leading to metabolic disorders”
Reviewunder metabolic stress
Hypothalamic inflammation in metabolic disorders and aging
Cellular and molecular life sciences : CMLS
Gut dysbiosis
upin reviews1
1 study
Gut dysbiosis
upin reviews1
Gut dysbiosis induces metabolic disease.
“gut dysbiosis can trigger metabolic diseases”
Review
Modifiable Risk Factors for Dementia: The Role of Gut Microbiota
Current Alzheimer research
SIRT6
downin reviews1
1 study
SIRT6
downin reviews1
SIRT6 protects against metabolic disease.
“SIRT6 protects against aging-associated pathologies including metabolic disease and cancer”
Review
SIRT6: Novel Mechanisms and Links to Aging and Disease
Trends in endocrinology and metabolism: TEM
PLIN2
downin mice1
1 study
PLIN2
downin mice1
PLIN2 decreases metabolic disease in mice (downregulation).
“In particular, its downregulation in mice prevents or mitigates some of the above mentioned diseases.”
Reviewdownregulation
Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective
Trends in endocrinology and metabolism: TEM
Associations
82Mortality
upin humans4HR 1.1
4 studies
Mortality
upin humans4HR 1.1
Metabolic disease is associated with mortality in humans (upper gastrointestinal cancer) (from 2.0 to 4.2 per 100,000).
“Overall AAMRs increased from 2.0 to 4.2 per 100,000, with a significant rise from 1999 to 2009 (APC 4.30%; 95% CI, 2.97–5.56; p < 0.01)”
Humansupper gastrointestinal cancer1999-2020n = 45,086
BMC public health
Metabolic disease is linked with a higher risk of mortality in humans (advanced non-small cell lung cancer) (HR 1.10, 95% CI 1.04-1.16).
“Veterans with metabolic diseases (24.7% of all patients; hazard ratio [HR] [95% confidence interval (CI)], 1.10 [1.04-1.16])”
Humansadvanced non-small cell lung cancern = 10,160
Annals of the American Thoracic Society
Metabolic disease is associated with mortality in humans after free-flap reconstruction (Alive: 33.90% vs. Dead: 54.50%; p = 0.031).
“metabolic diseases (Alive: 33.90% vs. Dead: 54.50%; p = 0.031) more frequently”
Humansafter free-flap reconstructionn = 147
Diagnostics (Basel, Switzerland)
Metabolic disease raises the risk of mortality in humans.
“Data suggest that SARS-CoV-2 patients with concomitant metabolic diseases had higher risk of worse prognosis and mortality.”
Review
Covid-19 Pandemic and Metabolic Aging
Acta scientific neurology
Obesity
upin humans3
3 studies
Obesity
upin humans3
Obesity is associated with metabolic disease in humans (p < 0.05).
“Obesity based on waist circumference was significantly positively associated with all metabolic diseases (all, p < 0.05).”
Humans
Obesity science & practice
Obesity is linked with a higher risk of metabolic disease in humans (p < 0.05).
“Men with obesity based on body mass index had a significantly high risk of hypertension, diabetes mellitus, and dyslipidemia across all age groups (all, p < 0.05).”
Humansmales
Obesity science & practice
Obesity is linked with a higher risk of metabolic disease in humans (Polish elderly).
“Being overweight or having obesity, as well as following a diet, increased the probability of being affected by metabolic disease.”
HumansPolish elderlyn = 417
Life (Basel, Switzerland)
Obesity raises the risk of metabolic disease in older population.
“Over half of the global older population were overweight or obese in 2010, significantly increasing the risk of a range of metabolic diseases.”
Reviewin older population
Obesity and the dysregulation of fatty acid metabolism: implications for healthy aging
Expert review of endocrinology & metabolism
Cellular senescence
upin reviews2mixedin reviews1
3 studies
Cellular senescence
upin reviews2mixedin reviews1
Cellular senescence raises the risk of metabolic disease.
“cellular senescence promotes metabolic diseases, which in turn promote senescence.”
Review
The metabolic roots of senescence: mechanisms and opportunities for intervention
Nature metabolism
Cellular senescence is associated with metabolic disease.
“Evidence suggests that the complex process of senescence is involved in the development of a plethora of chronic diseases including metabolic and inflammatory disorders and tumorigenesis.”
Review
Hepatology (Baltimore, Md.)
Cellular senescence is associated with metabolic disease (context-dependent protective versus deleterious roles).
“contradictory findings with regard to a protective versus deleterious role of senescent cells in certain contexts”
Reviewcontext-dependent protective versus deleterious roles
Cellular senescence: Implications for metabolic disease
Molecular and cellular endocrinology
Estrogen deficiency
upin humans2
2 studies
Estrogen deficiency
upin humans2
Estrogen deficiency raises the risk of metabolic disease in humans during menopause.
“Age-associated loss of estrogen production during menopause has been implicated in a higher risk for metabolic diseases and increased mortality.”
Reviewduring menopause
Exploring the effects of estrogen deficiency and aging on organismal homeostasis during menopause
Nature aging
estrogen deficiency raises the risk of metabolic disease in humans (postmenopausal women).
“Estrogen deficiency, such as in postmenopausal women, impairs PPAR regulation, leading to lipid accumulation and increased risk of metabolic disorders.”
Reviewpostmenopausal womenfemales
Regulation of Mitochondrial and Peroxisomal Metabolism in Female Obesity and Type 2 Diabetes
International journal of molecular sciences
FOXOPROTEINS
upin reviews1mixedin reviews1
2 studies
FOXOPROTEINS
upin reviews1mixedin reviews1
FOXOPROTEINS is associated with metabolic disease (dysregulation).
“The dysregulation of FOXO proteins has been established as pivotal in metabolic disorders, human longevity, and the inhibition of tumorigenesis.”
Reviewdysregulation
FOXO Transcription Factors: A Brief Overview
Methods in molecular biology (Clifton, N.J.)
FOXOPROTEINS is associated with metabolic disease.
“deregulation of FOXO proteins has been shown to play an essential role in metabolic disorders, human longevity, and the suppression of tumors”
Review
Methods in molecular biology (Clifton, N.J.)
Diet
upin humans2
2 studies
Diet
upin humans2
Diet is associated with metabolic disease in humans (Polish elderly).
“following a diet, increased the probability of being affected by metabolic disease.”
HumansPolish elderlyn = 417
Life (Basel, Switzerland)
Diet is associated with metabolic disease in humans (literature review).
“Suboptimal nutrition and eating disorders currently reported at both population and individual levels model the effects associated with the risk of metabolic disorders”
Reviewliterature review
Obesity and key predictors of its risk
Voprosy pitaniia
NAD+
upin humans1downin reviews1OR 3.01
2 studies
NAD+
upin humans1downin reviews1OR 3.01
NAD+ is associated with metabolic disease in humans (Highest versus lowest NAD+ quartile (≤29.4 μmol/L)) (Adjusted OR 3.01 (95% CI 1.87–4.87), highest versus lowest quartile).
“Increased NAD+ was significantly associated with MD, as well as its individual components.”
HumansHighest versus lowest NAD+ quartile (≤29.4 μmol/L)whole bloodn = 1,394
Association of NAD⁺ levels with metabolic disease in a community-based study
Frontiers in endocrinology
NAD+ is associated with metabolic disease.
“a decline in NAD levels is closely related to the development of various metabolic disorders, including diabetes and fatty liver disease”
Review
Implications of altered NAD metabolism in metabolic disorders
Journal of biomedical science
SIRT1
mixedin silico1upin reviews1
2 studies
SIRT1
mixedin silico1upin reviews1
SIRT1 is associated with metabolic disease in silico (bioinformatic analysis of public gene expression profiles).
“SIRT1 was associated with obesity-related genes and metabolic disorders.”
In silicobioinformatic analysis of public gene expression profiles
Potential biomarkers of Alzheimer's disease and cerebral small vessel disease
Frontiers in molecular neuroscience
SIRT1 is associated with metabolic disease (aberrant glycosylation).
“Aberrant glycosylation of SIRT1 is associated with aging and/or metabolic diseases.”
Reviewaberrant glycosylation
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Sirtuin signaling
downin reviews1mixedin reviews1
2 studies
Sirtuin signaling
downin reviews1mixedin reviews1
Sirtuin signaling lowers the risk of metabolic disease.
“SIRTs play essential roles in ameliorating obesity and age-related metabolic diseases.”
Review
Sirtfoods: New Concept Foods, Functions, and Mechanisms
Foods (Basel, Switzerland)
Sirtuin signaling is associated with metabolic disease.
“SIRT3, SIRT4, and SIRT5 are implicated in a range of disease-states including metabolic disease such as diabetes, neurodegenerative diseases, cancer, and ageing-related disorders”
Review
The role of mitochondrial sirtuins in health and disease
Free radical biology & medicine
Inflammation
mixedin humans1upin reviews1
2 studies
Inflammation
mixedin humans1upin reviews1
Inflammation is associated with metabolic disease in humans (multimorbidity).
“we focus on chronic inflammation as a key common pathological basis of cardiovascular and metabolic diseases”
Reviewmultimorbidity
Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity
Frontiers in cardiovascular medicine
Inflammation raises the risk of metabolic disease.
“Inflammatory infiltrate and altered immune cell phenotype precede development of metabolic disorders.”
Review
Epigenetics and Immunometabolism in Diabetes and Aging
Antioxidants & redox signaling
All 82Fewer
Trial sponsors
Company1 trialPhase 454 people
Company3 trialsPhase 3978 people
Company1 trialPhase 31,738 people
Company1 trialPhase 3354 people
Company1 trialPhase 3340 people
Company1 trialPhase 3210 people
Company1 trialPhase 340 people
Company1 trialPhase 2109 people
Funding
65 grants since 2016National Institute of Diabetes and Digestive and Kidney Diseases$14MNational Heart, Lung, and Blood Institute$6MNational Institute on Aging$1.8M
National Heart, Lung, and Blood InstituteCedars-Sinai Medical Center$854K2026–2030
Developing GLP-1 Producing Genetically Engineered Probiotics for Treatment of Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney DiseasesMedosome Biotec$356K2026–2027
Metabolic disease heterogeneity definition, prevention and remission with targeted interventions
European CommissionHelmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt€4.4M2027–2030
Canada Foundation for Innovation | Fondation canadienne pour l'innovationUniversité Laval2026
The 11S-associated immunoproteasome in mitochondrial function and metabolic disorders
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Minnesota$408K2023–2027
National Institute of Diabetes and Digestive and Kidney DiseasesMassachusetts General Hospital$79.5K2026–2029
Translational Research Program on PFAS and Metabolic Diseases: A Solution Oriented Framework
National Institute of Environmental Health SciencesUniversity of Southern California$1.3M2026–2034
Psychological and Epigenetic Predictors of Obesity & Metabolic Disease
National Institute of Diabetes and Digestive and Kidney DiseasesYale University$195K2024–2029
Mechanisms for Impaired Adaptation to Aerobic Exercise with Metabolic Disease
National Institute of Diabetes and Digestive and Kidney DiseasesVirginia Polytechnic Inst and St Univ$710K2020–2030
Leveraging arginase biology against metabolic disease
National Institute of Diabetes and Digestive and Kidney DiseasesIndiana University Indianapolis$440K2023–2027
How this record changed
Summary rewritten as its findings changed.
As it read before
In one human study of patients with obesity, vitamin B12 deficiency, vitamin D deficiency and prior underweight are associated with higher metabolic disease risk.
Summary written from the findings.